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Abstract
Background: Previous studies suggested the potential interactions between cerebrovascular diseases and impaired
renal function. However, the relationship between renal function and white matter hyperintensity (WMH), marker of
cerebral small vessel disease, in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA)
remains unknown.
Methods: We consecutively enrolled 1632 subjects with AIS or TIA who underwent brain MRI for this analysis.
The severity of WMH in both of periventricular (PVH) and deep subcortical white matter (SDWMH) was evaluated using
Fazekas scale. Estimated glomerular filtration rate (eGFR) was calculated by the equation of the Modification Diet
for Renal Disease. Multinomial logistic regression was performed to evaluate the association between the severity
of WMH and eGFR.
Results: Advanced age and hypertension were independently associated with the severity of both PVH and
SDWMH (all p < 0.001). There is a significantly inverse association between eGFR and PVH. Patients having each
30 ml/min/1.73 m2 increase in eGFR was associated with 75 % of risk of having degree 3 of WMH in periventricular
areas compared with degree 0 (p = 0.04, OR = 0.75, 95 % CI 0.61–0.92). However this inverse association was not found
between eGFR and SDWMH (P = 0.50, OR = 0.93, 95 % CI0.75–1.14).
Conclusion: Our study demonstrates that renal dysfunction (eGFR) is independently associated with the severity of
PVH but not SDWMH in patients with acute ischemic stroke. This results highlighted different pathological mechanism
and risk factors of PVH and SDWMH.
Keywords: Renal dysfunction, White matter hyperintensity, Chronic kidney disease, Stroke
Background
Chronic kidney disease has been recognized as a rapidly
growing global health burden in the past decade. Previ-
ous studies showed that individuals with an eGFR
below 60 mL/min per 1.73 m2 had a higher risk of
stroke and vice versa, suggesting the potential interac-
tions between cerebrovascular diseases and impaired
renal function [1, 2].
The regulation of the microvasculatures of brain and kid-
ney is functionally similar. In addition, kidney impairment
is characterized by glomerular endothelial dysfunction and
lipohyalinosis, both of which are features of small-
artery diseases [1, 3]. Thus people can readily presume
that there might be association between kidney func-
tion and silent MRI changes which related to cerebral
small vessel disease, like white matter hyperintensity
(WMH), lacune and microbleeds. Previous studies
showing independent associations between chronic kidney
disease (CKD) and WMH in individuals without stroke
supported the above mentioned hypothesis [4–6]. How-
ever, data on stroke patients have been subjected to debate
[7, 8]. WMH burden was related to increased risk of
stroke and unfavorable post-stroke outcomes, so was im-
paired renal function [9–11]. Therefore the relationship
between WMH and renal failure in ischemic stroke pa-
tients still needs more investigations. Moreover, although
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WMH in periventricular area and in deep white matter
were regarded to have different pathological features [12],
studies evaluated the lesions respectively in two locations
were rare.
In the present study based on data collected in a large
cohort of Chinese patients with acute ischemic stroke
(AIS) or transient ischemic attack (TIA), we aimed to
explore the potential risk factors of WMH, particularly
the association between renal function and WMH.
Methods
Patients
Data were obtained from the SMART study, a multicen-
ter trial designed to assess the effectiveness of a
guideline-based structured care program for secondary
stroke prevention in China. The complete study proto-
col, approved by the ethics committees at Peking Union
Medical College Hospital, has been detailed elsewhere
[13] and the reference number is S-151. Informed writ-
ten consent was obtained from each patient.
Briefly, between April 2008 and December 2010, a
total of 3821 patients, aged > 18 years, with cerebral is-
chemic infarct or TIA within 30 days were enrolled.
Patients who had severe comorbidities including heart
failure, respiratory failure, renal failure, severe liver
dysfunction, malignancy were excluded. For this study,
only the 1975 patients who had brain MRI examination
were included. 233 scans were excluded because of
motion artifacts, leaving 1752 patients for WMH evalu-
ation. Among patients who had WMH evaluation,
those who had missing data on cardiovascular risk fac-
tors were further excluded so that the final sample was
composed of 1632 subjects.
Definition of risk factors
A history of ischemic heart disease (IHD) was consid-
ered if a history of myocardial infarction, bypass cardiac
surgery, or angioplasty was recorded. Atrial fibrillation
(AF) was considered according to the electrocardiogram
manifestation on admission or previously documented
diagnosis. A history of ischemic stroke/TIA was consid-
ered according to previously documented diagnosis.
Diabetes mellitus (DM) was considered present when
fasting blood glucose level ≥ 7.0 mmol/L, or antidiabetic
drugs were taken or a current history of DM was
reported. Hypertension was defined by high blood pres-
sure (systolic blood pressure ≥ 140 mmHg or diastolic
blood pressure ≥ 90 mmHg), or by use of antihyper-
tensive drugs, or previous diagnosis. Hypercholesterol-
emia was defined as total cholesterol ≥ 5.2 mmol/L or
lipid-lowing drugs were taken or a current history was
documented. Smoking habits were categorized as non-
smokers and smokers (former or current). Admission
serum creatinine was abstracted from the medical
chart. Estimated glomerular filtration rate (eGFR) was
calculated using the equation of the Modification Diet
for Renal Disease modified by the Chinese coefficient
[14]: eGFR(ml/min/1.73 m2) = 186 × serum creatinine
(exp[−1.154]) × age (exp[−0.203]) × 1.233 × 0.742 (if
female). According to the eGFR, CKD stages were de-
fined as follow: stage1:eGFR ≥ 90 ml/min per 1.73 m2,
stage 2:60 ≤ eGFR < 90 ml/min per 1.73 m2, stage3:
30 ≤ eGFR < 60 ml/min per 1.73 m2, stage4: 15 ≤ eGFR
< 30 ml/min per 1.73 m2, stage5: eGFR < 15 ml/min
per 1.73 m2 [15].
Rating of WMH
The brain MRI scan had been performed on a 1.5-Tesla or
3.0-Tesla System due to different research centers, then
MRI scans were converted from DICOM to analysis
format by eZdicom software, and T2 fluid-attenuated in-
version recovery (FLAIR) sequences were used to evaluate
the degree of WMH. The Fazekas scale [16] was used to
score both the severity of periventricular WMH (PVH)
and deep subcortical WMH (SDWMH). All images were
analyzed by the same experienced reader (X.-F.L.) blinded
to all clinical data. The intra-rater agreement for the rating
of WMH was assessed on a random sample of 54 subjects
at 8-week intervals. The intrarater reliability analysis
showed a good reliability with κ values of 0.73 and 0.79
for PVH and SDWMH respectively.
Statistical analysis
The SPSS Version 19.0 was used for all analyses. The
descriptive statistics on the baseline characteristics are
presented as well as their crude distribution according
to WMH degrees. The continuous variables were sum-
marized as mean ± SD or median with interquartiles,
and all the categorical variables were presented as num-
ber (percent). Univariate analysis was used to evaluate
the relationship between WMH and other variables
(data not shown), and a nominal P value less than 0.2
was used to select variables to build the multinomial re-
gression model. For multinomial logistic regression, with
both PVH and SDWMH rated with a 4-degree score as
the dependent variable, each response category was con-
trasted against the reference category (degree 0). Each
model adjusted on age, gender and hypertension at least.
Statistical significance level for all analyses was set at P
value less than 0.05.
Results
Baseline characteristics of the study sample are shown in
Table 1. The mean age was 62.3 years (SD = 11.5) and
1118 (68.5 %) subjects were male. As the patients with
severe comorbid illness had been excluded on admission,
there are few people with CKD of stage 4 and 5 (5 for
stage 4 and none for stage 5), and only 59 (3.6 %)
Zong et al. BMC Neurology  (2016) 16:193 Page 2 of 6
patients had an eGFR below 60 ml/min per 1.73 m2 (Total
of CKD stage 3, 4 and 5).
Of 1632 participants, 811(49.7 %) had no WMH (degree
0) in the subcortical area, 575 (35.2 %) had SDWMH of
degree 1, leaving only 246 (15 %) with SDWMH of degree
2 or 3. By contrast, only 293 (18.0 %) participants had no
visible WMH in the periventricular area, 749 (45.9 %) par-
ticipants had PVH of degree 1, 590 (36.2 %) had PVH of
degree 2 or 3 (Table 1).
Renal function and other factors associated with the
severity of WMH
The baseline distribution of potential risk factors in rela-
tion to WMH degrees and their associations with PVH
as well as SDWMH are respectively shown in Tables 2
and 3. Mean age increased with WMH degree in both
brain locations (Table 2); each SD increase in age was
associated with a higher odds of having higher degrees
of WMH. This effect of age is more obvious in PVH
than in SDWMH, particularly in degree 3(OR for PVH:
6.98, 95 % CI 5.27–9.25; for SDWMH: 3.45, 95 % CI
2.63–4.53).
The proportion of individuals with hypertension
tended to increase with the degree of WMH; Similarly,
subjects with hypertension tended to have higher odds
of having higher degrees of PVH and SDWMH (P <
0.0001 for both PVH and SDWMH) as compared with
normotensive subjects (Tables 2 and 3).
We also observed that the median serum creatinine
level increased with WMH degree and median GFR de-
creased while the degree of WMH increased (Table 2).
After adjusted on age, gender and hypertension, patients
having each 30 ml/min/1.73 m2 increase in eGFR was
associated with 75 % of risk of having degree 3 of WMH
in periventrical areas as compared with having degree 0.
However, this inverse association was not found when
look at WMH in deep white matter (OR: 0.93, 95 % CI
0.75–1.14; P = 0.50, Table 3). There was no obvious
change after further adjustment on diabetes mellitus,
hypercholesterolemia, history of ischemic heart disease
and ischemic stroke/TIA. (Model 2, data not shown).
No significant associations were observed between
WMH and gender, smoking status, diabetes, hyperchol-
esterolemia, history of atrial fibrillation. Subjects with
history of ischemic heart disease had higher risk of
SDWMH (P = 0.05, Table 3), especially SDWMH of
degree2 versus degree 0 (OR:1.68, 95 % CI 1.01–2.79,
Table 3), but after further adjustment for diabetes melli-
tus, hypercholesterolemia and eGFR, the value of 1.0
was included in the confidence interval (Model 2, data
not shown). Subjects with history of ischemic stroke/
TIA had more WMH in both periventricular and sub-
cortical area (P < 0.001, Table 3), especially the highest
degree(For PVH, OR: 2.58, 95 % CI 1.62–4.11; For
SDWMH, OR:2.35, 95 % CI 1.53–3.59, Table 3). Further
adjustment for diabetes mellitus, hypercholesterolemia
and eGFR did not change the ORs obviously.
Discussion
This study, performed in a large cohort of patients with
AIS/TIA, found that renal function, as measured by
eGFR, is inversely associated with WMH in periventrical
areas. This association was independent of age, hyper-
tension and other vascular risk factors. However, no
association was found between eGFR and WMH in sub-
cortical deep white matter.
The association between decreased GFR and increased
WMH is in line with a study of 378 patients with
Table 1 Baseline characteristics of the participants
Characteristic Total
N (%)
Age, years* 62.3 ± 11.5
Male gender 1118 (68.5 %)
Smoking 776 (47.6 %)
Diabetes mellitus 508 (31.1 %)
Hypertension 1372 (84.1 %)
Hypercholesterolemia 723 (44.3 %)
Serum creatinine, umol/L 77.4 (65.9–90.0)
eGFR, ml/min/1.73 m2 106.9 (89.3–127.9)
Atrial fibrillation 69 (4.2 %)
Ischemic heart disease 187 (11.5 %)
History of ischemic stroke/TIA 434 (26.6 %)
CKD stages
Stage 1 1211 (74.2 %)
Stage 2 362 (22.2 %)
Stage 3 54 (3.3 %)
Stage 4 5 (0.3 %)
Stage 5 0 (0 %)
PVH degrees
Degree 0 293 (18.0 %)
Degree 1 749 (45.9 %)
Degree 2 416 (25.5 %)
Degree 3 174 (10.7 %)
SDWMH degrees
Degree 0 811 (49.7 %)
Degree 1 575 (35.2 %)
Degree 2 131 (8.0 %)
Degree 3 115 (7.0 %)
Variables are presented as mean ± SD (*), median (first-third quartile) or
number (percentage)
Abbreviations: eGFR estimated glomerular filtration rate, CKD chronic kidney
disease, PVH periventricular white matter hyperintensity, SDWMH subcortical
deep white matter hyperintensity
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ischemic stroke, which reported that eGFR < 60 mL/
min/1.73 m2 was associated with severe WMLs inde-
pendent of age and sex [8]. Most studies in the general
population also found this similar association. These
results suggested that kidney impairment might serve as
a predictive marker for the presence of white matter
lesions. However, our finding is in contrast with another
study of 523 subjects with acute ischemic stroke which
reported no significant association between eGFR and
WMH volume [7]. The discrepancy may be explained by
the varied definitions of clinical characteristics and the
different confounders corrected for from study to study.
On the other hand, stroke patients may have more risk
factors and more complicated pathogenesis underlying
WMH burden accumulation than general population, so
there are more controversies about the correlation be-
tween GFR and WMH in patients with acute ischemic
stroke.
We also found in our sample that the severity of both
PVH and SDWMH were significantly associated with
age, hypertension and a history of ischemic stroke/TIA.
This result is consistent with previous studies showing
that WMH burden is greater in individuals with com-
mon cerebrovascular risk factors [17]. Though these
vascular risk factors are also predictors for GFR decline
[18], we cannot determine whether the association be-
tween declined GFR and WMH observed in our study
is common consequence from shared risk factors or
Table 2 Baseline distribution of potential risk factors across the WMH degrees
PVH SDWMH
Degree0 Degree 1 Degree 2 Degree 3 Degree0 Degree 1 Degree 2 Degree 3
n = 293 n = 749 n = 416 n = 174 n = 811 n = 575 n = 131 n = 115
Age, mean years(SD) 53.6 (10.3) 61.5 (10.4) 65.9 (10.6) 71.7 (8.3) 58.4 (11.0) 64.7 (10.8) 67.7 (9.7) 71.3 (8.8)
Male gender 221 (75.4 %) 490 (65.4 %) 283 (68.0 %) 124 (71.3 %) 584 (72.0 %) 386 (67.1 %) 81 (61.8 %) 67 (58.3 %)
Smoking 170 (58.0 %) 343 (45.8 %) 186 (44.7 %) 77 (44.3 %) 417 (51.4 %) 268 (46.6 %) 53 (40.5 %) 38 (33.0 %)
Diabetes mellitus 77 (26.3 %) 260 (34.7 %) 125 (30.0 %) 46 (26.4 %) 242 (29.8 %) 201 (35.0 %) 33 (25.2 %) 32 (27.8 %)
Hypertention 211 (72.0 %) 635 (84.8 %) 366 (88.0 %) 160 (92.0 %) 640 (78.9 %) 508 (88.3 %) 120 (91.6 %) 104 (90.4 %)
Hypercholesterolemia 131 (44.7 %) 354 (47.3 %) 175 (42.1 %) 63 (36.2 %) 360 (44.4 %) 263 (45.7 %) 62 (47.3 %) 38 (33.0 %)
































Atrial fibrillation 7 (2.4 %) 30 (4.0 %) 21(5.0 %) 11 (6.3 %) 33 (4.1 %) 19 (3.3 %) 6 (4.6 %) 11(9.6 %)
Ischemic heart disease 22 (7.5 %) 72 (9.6 %) 67 (16.1 %) 26 (14.9 %) 72 (8.9 %) 64 (11.1 %) 27 (20.6 %) 24 (20.9 %)
Ischemic stroke/TIA 53 (18.1 %) 176 (23.5 %) 126 (30.3 %) 79 (45.4 %) 171 (21.1 %) 173 (30.1 %) 39 (29.8 %) 51 (44.3 %)
Table 3 Associations between risk factors and WMH degrees
N = 1632 PVH SDWMH
OR (95 % CI) OR (95 % CI)
Degree 1 vs 0 Degree 2 vs 0 Degree 3 vs 0 P Degree 1 vs 0 Degree 2 vs 0 Degree 3 vs 0 P
Agea 2.22 (1.88–2.62) 3.65 (3.01–4.43) 7.75 (5.93–10.13) < 0.001 1.81 (1.61–2.05) 2.45 (1.97–3.05) 3.83 (2.96–4.95) < 0.001
Male gender 0.79 (0.57–1.09) 1.06 (0.73–1.53) 1.51 (0.94–2.41) 0.004 0.95 (0.75–1.22) 0.82 (0.55–1.22) 0.77 (0.50–1.17) 0.56
Hypertension 1.96 (1.39–2.76) 2.56 (1.68–3.92) 4.06 (2.12–7.80) < 0.001 1.88 (1.37–2.58) 2.65 (1.38–5.08) 2.27 (1.16–4.43) < 0.001
eGFRb 0.89 (0.78–1.01) 0.92 (0.80–1.06) 0.75 (0.61–0.92) 0.04 0.96 (0.87–1.07) 0.87 (0.72–1.06) 0.93 (0.75–1.14) 0.50
Diabetes mellitus 1.25 (0.91–1.72) 0.98 (0.68–1.40) 0.84 (0.52–1.33) 0.08 1.16 (0.91–1.47) 0.71 (0.46–1.10) 0.83 (0.53–1.31) 0.09
Hypercholesterolemia 1.00 (0.75–1.34) 0.85 (0.61–1.19) 0.76 (0.50–1.17) 0.37 1.05 (0.84–1.32) 1.14 (0.77–1.67) 0.66 (0.43–1.02) 0.16
Smoking 0.83 (0.58–1.20) 0.85 (0.56–1.28) 0.97 (0.58–1.61) 0.70 1.12 (0.85–1.47) 1.03 (0.65–1.65) 0.85 (0.51–1.41) 0.70
Atrial fibrillation 1.00 (0.42–2.39) 1.02 (0.40–2.60) 1.05 (0.36–3.01) 1.00 0.56 (0.31–1.01) 0.67 (0.27–1.69) 1.23 (0.57–2.65) 0.12
Ischemic heart disease 0.69 (0.41–1.17) 1.04 (0.60–1.80) 0.80 (0.41–1.54) 0.15 0.91 (0.63–1.31) 1.68 (1.01–2.79) 1.52 (0.89–2.61) 0.05
Ischemic stroke/TIA 1.09 (0.76–1.56) 1.42 (0.96–2.10) 2.58 (1.62–4.11) < 0.001 1.36 (1.06–1.76) 1.27 (0.83–1.94) 2.35 (1.53–2.59) 0.001
Models of multinomial logistic regression adjusted on age, gender and hypertension. In each model, PVH or SDWMH was considered as the dependent variable
categorized in 4 degrees (0–3), and degree 0 was the reference category
aFor age, the OR estimates the association related to an increase of 1 SD
bFor eGFR, the OR estimates the association related to increase of 30 ml/min/1.73 m2
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represents a causative relationship, considering our re-
search design.
In our study, the severity of WMH was evaluated sep-
arately in two areas and those which located in deep
white matter was found not relate to renal function.
Our findings have suggested distinct involvement of
renal function in the process of WMH accumulation in
two locations. Previous studies have also reported that
different mechanism involved in the development of
PVH and SDWMH, and PVHs are more likely due to
diminished cerebral vasomotor reactivity and subse-
quent hypoperfusion, while SDWMHs are related to
microangiopathy [12, 19, 20]. However, only a few stud-
ies detected the correlation of GFR with PVH and
SDWMH separately. A recent study which distin-
guished the relationship of GFR with PVH and
SDWMH in a large cohort of patients without stroke
history showed that eGFR < 60 ml/min/1.73 m2 is sig-
nificantly associated with both PVH and SDWMH [21].
In contrast with our study, they targeted population
without history of stroke or other cardiovascular
events, and the proportion of subjects with potential
risk factors in their study is low, thus the contribution
of renal dysfunction to WMH may be augmented.
There are several limitations should be noted in our
study. First, considered that it was a multicenter de-
signed study and the serum creatinine concentration
had been analyzed in different laboratories, there may be
bias of measurement. However, the comparability of
serum creatinine concentration detected in different lab
was widely accepted in previous studies, and all of the
involved centers have rigid quality control process of their
clinical and biochemical tests, we think this may not
change our results. Second, the WMH assessment had
been performed using visual rating scale. Although also
widely used, visual rating may be less precise or consistent
than quantitative evaluation. Last, as we have excluded
subjects with severe renal dysfunction, the proportion of
patients with eGFR < 60 ml/min/1.73 m2 is lower (only
3.6 %) in our cohort than previous reported (28.1 % in one
study and 40.2 % in another) [8, 22], which may underesti-
mate the association of eGFR over WMH.
Conclusion
In conclusion, we demonstrated that kidney function is
associated with WMH in patients having acute ischemic
stroke or TIA. Furthermore, this association was found
only in WMH located around ventricles. Further studies
are needed to improve our understanding of this
cerebro-renal coexisting impairment.
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